These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 12596755)
1. Hemodialysis vascular access dysfunction: from pathophysiology to novel therapies. Roy-Chaudhury P; Kelly BS; Zhang J; Narayana A; Desai P; Melham M; Duncan H; Heffelfinger SC Blood Purif; 2003; 21(1):99-110. PubMed ID: 12596755 [TBL] [Abstract][Full Text] [Related]
2. Vascular access in hemodialysis: issues, management, and emerging concepts. Roy-Chaudhury P; Kelly BS; Melhem M; Zhang J; Li J; Desai P; Munda R; Heffelfinger SC Cardiol Clin; 2005 Aug; 23(3):249-73. PubMed ID: 16084276 [TBL] [Abstract][Full Text] [Related]
3. Aggressive venous neointimal hyperplasia in a pig model of arteriovenous graft stenosis. Kelly BS; Heffelfinger SC; Whiting JF; Miller MA; Reaves A; Armstrong J; Narayana A; Roy-Chaudhury P Kidney Int; 2002 Dec; 62(6):2272-80. PubMed ID: 12427156 [TBL] [Abstract][Full Text] [Related]
4. Novel therapies for hemodialysis vascular access dysfunction: fact or fiction! Roy-Chaudhury P; Kelly BS; Melhem M; Zhang J; Li J; Desai P; Munda R; Heffelfinger SC Blood Purif; 2005; 23(1):29-35. PubMed ID: 15627734 [TBL] [Abstract][Full Text] [Related]
5. Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Lee T; Roy-Chaudhury P Adv Chronic Kidney Dis; 2009 Sep; 16(5):329-38. PubMed ID: 19695501 [TBL] [Abstract][Full Text] [Related]
6. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. Roy-Chaudhury P; Sukhatme VP; Cheung AK J Am Soc Nephrol; 2006 Apr; 17(4):1112-27. PubMed ID: 16565259 [TBL] [Abstract][Full Text] [Related]
12. Maintenance of adequate hemodialysis access. Prevention of neointimal hyperplasia. Taber TE; Maikranz PS; Haag BW; Gaylord GM; Dilley RS; Ehrman KO; Brown PB; Nelson DR; Kay DC; Roberts TL ASAIO J; 1995; 41(4):842-6. PubMed ID: 8589464 [TBL] [Abstract][Full Text] [Related]
13. Endothelial progenitor cells, neointimal hyperplasia, and hemodialysis vascular access dysfunction: novel therapies for a recalcitrant clinical problem. Roy-Chaudhury P Circulation; 2005 Jul; 112(1):3-5. PubMed ID: 15998692 [No Abstract] [Full Text] [Related]
14. New Developments in Our Understanding of Neointimal Hyperplasia. Lee T; Ul Haq N Adv Chronic Kidney Dis; 2015 Nov; 22(6):431-7. PubMed ID: 26524947 [TBL] [Abstract][Full Text] [Related]
16. Clinical protocol. A phase IIb, randomized, multicenter, double-blind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients. Fuster V; Charlton P; Boyd A Hum Gene Ther; 2001 Nov; 12(16):2025-7. PubMed ID: 11727735 [TBL] [Abstract][Full Text] [Related]
17. Radiation therapy for dialysis access stenosis: unfulfilled promise or false expectations. Ahmed S; Roy-Chaudhury P Semin Dial; 2012 Jul; 25(4):464-9. PubMed ID: 22276964 [TBL] [Abstract][Full Text] [Related]
18. Genetic causation of neointimal hyperplasia in hemodialysis vascular access dysfunction. Lee T; Wadehra D Semin Dial; 2012; 25(1):65-73. PubMed ID: 21917012 [TBL] [Abstract][Full Text] [Related]